We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+2.51%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11.9B
AUM Growth
-$755M
Cap. Flow
-$1.47B
Cap. Flow %
-12.34%
Top 10 Hldgs %
33.73%
Holding
1,207
New
25
Increased
513
Reduced
317
Closed
41

Top Buys

Rank Stock Value
1
WELL icon
Welltower
WELL
+$281M
2
DOC icon
Healthpeak Properties
DOC
+$233M
3
LSI
Life Storage, Inc.
LSI
+$141M
4
CONE
CyrusOne Inc Common Stock
CONE
+$139M
5
ESS icon
Essex Property Trust
ESS
+$99.1M

Top Sells

Rank Stock Value
1
BXP icon
Boston Properties
BXP
+$240M
2
HST icon
Host Hotels & Resorts
HST
+$190M
3
HR icon
Healthcare Realty
HR
+$160M
4
DLR icon
Digital Realty Trust
DLR
+$157M
5
CCI icon
Crown Castle
CCI
+$153M

Sector Composition

Rank Sector Weight
1 Real Estate 71.54%
2 Technology 3.97%
3 Industrials 3.48%
4 Financials 2.88%
5 Healthcare 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
1051
DELISTED
Esperion Therapeutics
ESPR
$6K ﹤0.01%
145
– –
LXRX icon
1052
Lexicon Pharmaceuticals
LXRX
$1.02B
$6K ﹤0.01%
583
– –
OMER icon
1053
Omeros
OMER
$709M
$6K ﹤0.01%
265
– –
QURE icon
1054
uniQure
QURE
$2.68B
$6K ﹤0.01%
170
– –
TVTX icon
1055
Travere Therapeutics
TVTX
$5.33B
$6K ﹤0.01%
217
– –
VNDA icon
1056
Vanda Pharmaceuticals
VNDA
$312M
$6K ﹤0.01%
248
– –
EGRX
1057
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$6K ﹤0.01%
82
– –
ALDR
1058
DELISTED
Alder Biopharmaceuticals
ALDR
$6K ﹤0.01%
374
– –
AMPH icon
1059
Amphastar Pharmaceuticals
AMPH
$825M
$5K ﹤0.01%
254
– –
CERS icon
1060
Cerus
CERS
$587M
$5K ﹤0.01%
630
– –
CHRS icon
1061
Coherus Oncology
CHRS
$217M
$5K ﹤0.01%
320
– –
CNP icon
1062
PUT
CenterPoint Energy
CNP
$29.1B
$5K ﹤0.01%
+500
New +$14K
IOVA icon
1063
Iovance Biotherapeutics
IOVA
$2.23B
$5K ﹤0.01%
401
– –
RVNC
1064
DELISTED
Revance Therapeutics, Inc.
RVNC
$5K ﹤0.01%
202
– –
ACOR
1065
DELISTED
Acorda Therapeutics
ACOR
$5K ﹤0.01%
2
– –
ATNX
1066
DELISTED
Athenex, Inc. Common Stock
ATNX
$5K ﹤0.01%
16
– –
ECYT
1067
DELISTED
Endocyte, Inc. Common Stock
ECYT
$5K ﹤0.01%
265
– –
ADAP
1068
DELISTED
Adaptimmune Therapeutics
ADAP
$4K ﹤0.01%
323
– –
ANIP icon
1069
ANI Pharmaceuticals
ANIP
$1.77B
$4K ﹤0.01%
64
– –
BCRX icon
1070
BioCryst Pharmaceuticals
BCRX
$2.37B
$4K ﹤0.01%
544
– –
CTMX icon
1071
CytomX Therapeutics
CTMX
$705M
$4K ﹤0.01%
212
– –
KPTI icon
1072
Karyopharm Therapeutics
KPTI
$168M
$4K ﹤0.01%
17
– –
MGNX icon
1073
MacroGenics
MGNX
$235M
$4K ﹤0.01%
203
– –
TVRD
1074
Tvardi Therapeutics
TVRD
$23.5M
$4K ﹤0.01%
5
– –
RDUS
1075
DELISTED
Radius Health, Inc.
RDUS
$4K ﹤0.01%
246
– –
41 42
43
44 45

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2018 Portfolio in Review

As of Q3 2018, Daiwa Securities Group held 1,207 positions worth $11.9B, down 5.9% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group withdrew a net $1.47B in Q3 2018, closing 41 positions and reducing 317 holdings. Its most notable exit was SITE Centers, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 72% of assets, down from 73% a quarter earlier, followed by Technology and Industrials.

Against the trend, Daiwa Securities Group opened a new position in Altaba Inc worth $4.33M.

  • Daiwa Securities Group's largest Q3 2018 buy was Altaba Inc: 63,550 shares worth $4.33M.
  • Daiwa Securities Group added most to Welltower in Q3 2018, an estimated $281M increase.
  • Daiwa Securities Group's biggest Q3 2018 reduction was Boston Properties, cutting an estimated $240M.
  • Daiwa Securities Group fully exited SITE Centers in Q3 2018, selling an estimated $128M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $11.9B portfolio in Q3 2018.
  • Daiwa Securities Group opened 25 new positions and closed 41 in Q3 2018.
  • Daiwa Securities Group's portfolio value fell 5.9% quarter-over-quarter to $11.9B.

Based on Daiwa Securities Group's 13F filing for Q3 2018, filed 1 Nov 2018.